Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
AORT Artivion
14.030-0.090-0.64%
Close
02/03 16:00 ET
14.0300.0000.00%
Post Mkt Price 02/03 16:03 ET
High
14.490
Open
14.040
Turnover
2.87M
Low
13.970
Pre Close
14.120
Volume
202.62K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Artivion (NYSE:AORT) Is Making Moderate Use Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only n
SG Americas Securities LLC Invests $187,000 in Artivion, Inc. (NYSE:AORT)
SG Americas Securities LLC bought a new position in shares of Artivion, Inc. (NYSE:AORT – Get Rating) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Com
Artivion, Inc. (NYSE:AORT) Shares Acquired by Great West Life Assurance Co. Can
Great West Life Assurance Co. Can lifted its stake in Artivion, Inc. (NYSE:AORT – Get Rating) by 11.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. T
Head to Head Survey: Aethlon Medical (NASDAQ:AEMD) Vs. Artivion (NYSE:AORT)
Aethlon Medical (NASDAQ:AEMD – Get Rating) and Artivion (NYSE:AORT – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on
Reviewing Artivion (NYSE:AORT) and Aethlon Medical (NASDAQ:AEMD)
Aethlon Medical (NASDAQ:AEMD – Get Rating) and Artivion (NYSE:AORT – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the
$7 Billion Worldwide Medical Lasers Industry to 2027 - Players Include Artivion, Bausch Health Companies, BIOLASE and Boston Scientific
DUBLIN, Dec. 29, 2022 /PRNewswire/ -- The "Medical Lasers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's
Insider Selling: Artivion, Inc. (NYSE:AORT) CAO Sells 3,226 Shares of Stock
Artivion, Inc. (NYSE:AORT – Get Rating) CAO Amy Horton sold 3,226 shares of the company's stock in a transaction on Wednesday, December 14th. The shares were sold at an average price of $13.57, for a
Vapotherm (NYSE:VAPO) Versus Artivion (NYSE:AORT) Head to Head Survey
Vapotherm (NYSE:VAPO – Get Rating) and Artivion (NYSE:AORT – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the st
Should You Invest in Artivion (AORT) for a Long-Term Benefit?
Public Sector Pension Investment Board Buys Shares of 74,420 Artivion, Inc. (NYSE:AORT)
Public Sector Pension Investment Board purchased a new position in Artivion, Inc. (NYSE:AORT – Get Rating) during the second quarter, according to its most recent 13F filing with the Securities and
Company Overview
More
CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.
CEO： Mr. James Patrick Mackin
Market： NYSE
Listing Date： 07/15/1997
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet